|
Topics and Briefing Documents
HEALTH AND WELFARE
CONTROLS ON ANIMAL MEDICINES
ANTIBIOTICS
ANIMALS IN RESEARCH
ORGANOPHOSPHATES
SAFETY OF FOOD & RESIDUES
VACCINES
ADVERTISING
ADVERSE REACTIONS
ENVIRONMENT
CONSUMER ATTITUDES
|
|
Pet GSL medicines not under
EU threat
Following the publication on 27 January 2002 of a misleading article in
the Sunday Telegraph, which wrongly implied that all animal medicines
would be restricted to being Prescription-Only (POM), there is some concern that GSL pet
medicines' future is threatened.
Contrary to what appeared in the newspaper article
- the proposal from the European Commission to move to POM applies to farm
livestock only (including horses) but not pets.
- it is a proposal only, and far from agreed - the UK government is
opposed, as are many MEPs
- even if the proposal were agreed, it would not take effect until at
least 2005.
The proposal from the European Commission is intended to bring the main
medicines directive into line with the directive on residues in meat and milk for human
consumption - it has nothing to do with pet medicines, and will not affect them.
As background, the farm animal medicine clause is one part of a huge
document, which sets out to maximise the efficiency of the stringent European licensing
systems that control both human and animal medicines. Much in the proposals is good and
could improve availability of medicines: the danger is that this one small clause could
cause, potentially, much harm to farm animal and horse welfare and the British businesses
- merchants and saddlers - that are registered through AMTRA to sell PML products such as
wormers.
NOAH is delighted that the UK government has taken a stand in Europe
for continued flexibility on this issue. If they are successful then every member state
will still be able to use the systems of animal medicine distribution that have developed
to meet their own particular needs - to protect consumers, yet still keep medicines
available for the benefit of animal welfare. As the European Council continues to discuss
the proposal, and it is put before the European Parliament, let's hope others take the
same pragmatic view.
NOAH
4 February 2002 |